SCHEMBL13408971

SCHEMBL13408971

c1ccc(-c2cc3cc(-c4ccc(N(c5ccccc5)c5ccc6ccccc6c5)cc4)c4ccccc4c3c3ccccc23)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.38
KDM4E B2RXH2 5/20 0.38
MEN1 O00255 4/20 0.38
KMT2A Q03164 4/20 0.38
MAPT P10636 4/20 0.38
HPGD P15428 4/20 0.38
MPI P34949 1/20 0.38
PTGS2 P35354 1/20 0.36
GPR84 Q9NQS5 4/20 0.35
PSMB5 P28074 2/20 0.35
ACACA Q13085 1/20 0.35
L3MBTL1 Q9Y468 3/20 0.34
MAPK1 P28482 2/20 0.34
TDP1 Q9NUW8 2/20 0.34
USP2 O75604 1/20 0.34
CTNNB1 P35222 1/20 0.34
ATM Q13315 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34
GSTP1 P09211 1/20 0.34
CYP1A2 P05177 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13408940 0.98 ALDH1A1 (0.39) ALDH1A1KDM4EMEN1KMT2AMAPT
SCHEMBL13408777 0.98 GPR84 (0.36) ALDH1A1KDM4EMEN1KMT2AMAPT
SCHEMBL13408993 0.97 GPR84 (0.39) ALDH1A1KDM4EMEN1KMT2AMAPT
SCHEMBL13408991 0.96 GPR84 (0.40) ALDH1A1KDM4EMEN1KMT2AMAPT
SCHEMBL13408765 0.95 GSTP1 (0.37) ALDH1A1KDM4EMEN1KMT2AMAPT
SCHEMBL13409015 0.94 GPR84 (0.39) ALDH1A1KDM4EMEN1KMT2AMAPT
SCHEMBL13408986 0.94 GSTP1 (0.41) ALDH1A1KDM4EMAPTHPGDGPR84
SCHEMBL13408964 0.94 GSTP1 (0.41) ALDH1A1KDM4EMAPTHPGDGPR84
SCHEMBL13408776 0.94 GSTP1 (0.41) ALDH1A1KDM4EMAPTHPGDGPR84
SCHEMBL13409001 0.94 GSTP1 (0.41) ALDH1A1KDM4EMEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100096982-A1 Novel organic electroluminescent compounds and organic electrouminescent device using the same GRACEL DISPLAY INC. (KR) 2010-04-22 US disclosed
US-20100096982-A1 Novel organic electroluminescent compounds and organic electrouminescent device using the same GRACEL DISPLAY INC. (KR) 2010-04-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100096982-A1 Novel organic electroluminescent compounds and organic electrouminescent device using the same OCIAD1, OR10J3, ORMDL3 ALDH1A1 208/4885KDM4E 4170/4885MEN1 3162/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.